New drug helps extend survival rate of men with advanced prostate cancer: B.C. Cancer Agency study

10 June 2019 - At two years, advanced prostate cancer patients taking the trial drug, in addition to their standard treatment, ...

Read more →

Patients, physicians raise concerns with BC biosimilar non-medical switching policy

6 June 2019 - On 27 May, the Government of British Columbia announced a policy that will forcibly switch thousands ...

Read more →

Canadian Biosimilars Forum applauds B.C. Government's landmark decision to enhance adoption of biosimilars and calls on remaining provinces to follow

27 May 2019 - The Canadian Biosimilars Forum today commends the Government of British Columbia for taking a decisive step ...

Read more →

BC PharmaCare’s Biosimilars Initiative an important step towards improving patient access to safe and effective medicines

27 May 2019 - Biosimilars Initiative implementation could contribute to significant cost savings for the BC health care system. ...

Read more →

B.C. becomes first province to force change to biosimilar drugs

27 May 2019 - The change will save the government nearly $100 million over the next three years. ...

Read more →

Glatect added to public drug plan in British Columbia as sole RRMS treatment of its type

11 December 2018 - Pendopharm’s Glatect (glatiramer acetate) — a treatment for patients with relapsing-remitting multiple sclerosis — has been added ...

Read more →

Renflexis (infliximab for injection) added to British Columbia's Provincial Drug Plan for all approved indications

22 August 2018 - Renflexis has been added to drug formulary for the treatment of adult and paediatric Crohn's disease and ...

Read more →

B.C. to sue opioid makers for health care expenses of overdose crisis

29 August 2018 - The British Columbia Government will sue opioid manufacturers including Purdue Pharma in an effort to recoup ...

Read more →

Cystic fibrosis patients launch class-action suit over access to costly drug

24 July 2018 - A young Victoria woman with cystic fibrosis who fought to get coverage of a life-changing drug ...

Read more →

B.C. charity fights feds for access to life-saving medicine

5 July 2018 - Cure SMA Canada is urging the federal government to reimburse the costs of Spinraza. ...

Read more →

B.C., where access to a wait-list is considered access to health care

8 May 2018 - Last month, the British Columbia government decided to get tough with private health-care clinics, announcing that ...

Read more →

British Columbia and Prince Edward Island become the first provinces to add Erelzi (etanercept) to public drug plans for the treatment of multiple inflammatory diseases

16 November 2017 - Erelzi also becomes the first biosimilar indicated for polyarticular juvenile idiopathic arthritis under these provincial public drug ...

Read more →

Provincial drug plans, including Ontario and BC, make Entyvio (vedolizumab) available to treat inflammatory bowel disease

9 May 2017 - Gut-selective treatment now funded publicly for Canadians with ulcerative colitis and Crohn's disease. ...

Read more →

Hope of B.C. coverage for life-saving cystic fibrosis drug dashed

23 March 2017 - 'It's about dollars,' says father of 16-year-old who claims son's life was changed by access to the ...

Read more →

British Columbia lists Epclusa on public drug plan to treat all six genotypes of chronic hepatitis C infection

21 March 2017 - British Columbia also broadens access for patients with less advanced disease who have other health conditions. ...

Read more →